Jacob Asset Management of New York’s OptimizeRx OPRX Stock Holding History

Jacob Asset Management of New York’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.88M	Buy	370,330 +85,720	+30%	+$933K	4.06%	5
2023 Q2	$4.07M	Buy	284,610 +140	+0%	+$1.99K	4.58%	2
2023 Q1	$4.16M	Buy	284,470 +10,000	+4%	+$167K	4.85%	1
2022 Q4	$4.61M	Sell	274,470 -26,434	-9%	-$457K	5.61%	2
2022 Q3	$4.46M	Buy	300,904 +60,843	+25%	+$1.2M	4.84%	3
2022 Q2	$6.58M	Sell	240,061 -15,984	-6%	-$474K	6.64%	1
2022 Q1	$9.57M	Sell	256,045 -29,356	-10%	-$1.3M	5.82%	1
2021 Q4	$17.7M	Sell	285,401 -42,743	-13%	-$3.24M	7.91%	1
2021 Q3	$28.1M	Sell	328,144 -9,724	-3%	-$610K	10.2%	1
2021 Q2	$20.9M	Buy	337,868 +20,000	+6%	+$1.02M	6.9%	1
2021 Q1	$15.5M	Buy	317,868 +21,800	+7%	+$1.05M	6%	2
2020 Q4	$9.22M	Buy	+296,068	New	+$7.25M	6.98%	2

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Jacob Asset Management of New York's OPRX Position: Q3 2023 in Review

Jacob Asset Management of New York increased its OptimizeRx (OPRX) stake by 30% in Q3 2023, buying an estimated $933K and bringing the position to 370,330 shares worth $2.88M. The position accounts for 4.06% of the portfolio, ranked #5.

Jacob Asset Management of New York first reported a position in OPRX in Q4 2020 and has held it in 12 quarters since. The position peaked at $28.1M in Q3 2021. 94 funds tracked by Wall St. Rank hold OPRX as of Q3 2023.

Jacob Asset Management of New York held 370,330 shares of OptimizeRx worth $2.88M as of Q3 2023.
Jacob Asset Management of New York bought 85,720 OptimizeRx shares in Q3 2023, an estimated $933K.
OptimizeRx made up 4.06% of Jacob Asset Management of New York's portfolio in Q3 2023, its #5 holding.
Jacob Asset Management of New York first reported a position in OptimizeRx in Q4 2020 and has held it in 12 quarters since.
Jacob Asset Management of New York's OptimizeRx position peaked at $28.1M in Q3 2021.
94 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2023.

Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.